BECN2 Protein

📖 Wiki Page

protein1039 wordssynced 2026-04-02

BECN2 Protein (Beclin-2)

Introduction

Becn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<div class="infobox infobox-protein"> [@klionsky2016]
<table> [@galluzzi2017]
<tr><th colspan="2" style="background:#e8f4ea;">BECN2 Protein</th></tr> [@bento2016]
<tr><td><b>Protein Name</b></td><td>Beclin-2</td></tr> [@karan2021]
<tr><td><b>Gene</b></td><td>[BECN2](/genes/becn2)</td></tr> [@nah2020]
<tr><td><b>UniProt ID</b></td><td>Q9U6C4</td></tr> [@wang2012]
<tr><td><b>Molecular Weight</b></td><td>46.2 kDa</td></tr> [@he2012]
<tr><td><b>Subcellular Localization</b></td><td>Golgi apparatus, Endosomes, Cytoplasm</td></tr>
<tr><td><b>Protein Family</b></td><td>Beclin family, PI3K complex</td></tr>
<tr><td><b>Chromosomal Location</b></td><td>5q13.2</td></tr>
<tr><td><b>Associated Diseases</b></td><td>Alzheimer's Disease, Parkinson's Disease, Huntington's Disease, ALS, Obesity, Cancer</td></tr>
</table>
</div>

Overview

BECN2 (Beclin-2) is a key regulator of autophagy that interacts with class I PI3K signaling pathways. It plays critical roles in both macroautophagy and selective autophagy, particularly targeting misfolded proteins and protein aggregates. BECN2 serves as a molecular bridge between nutrient sensing, growth factor signaling, and the autophagy machinery.

Protein Structure

...

BECN2 Protein (Beclin-2)

Introduction

Becn2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Protein Structure

| Domain | Position | Function |
|--------|----------|----------|
| BH3 domain | 1-30 | Pro-apoptotic, binds Bcl-2 |
| CCD (Coiled-Coil Domain) | 112-243 | Dimerization, protein interactions |
| ECD (Evolutionarily Conserved Domain) | 244-450 | PI3K complex binding, membrane association |
| LIR (LC3-Interacting Region) | 269-280 | Autophagosome recruitment |

Expression Pattern

BECN2 exhibits tissue-specific expression:

Brain: High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum
[Neurons](/entities/neurons): Particularly abundant in pyramidal neurons and Purkinje cells
Glia: Moderate expression in [astrocytes](/entities/astrocytes) and [microglia](/entities/microglia)
Peripheral: Heart, liver, skeletal muscle with lower levels
Development: Increased expression during synaptic plasticity periods

Normal Function

Autophagy Initiation

BECN2 forms part of the PI3K complex (VPS34/VPS15/BECN2) that generates PI3P on isolation membranes, a critical step in autophagosome nucleation.

Selective Autophagy Receptor

Aggregate clearance: Recruits ubiquitinated protein aggregates to autophagosomes
Organelle quality control: Mitophagy, reticulophagy
Pathogen clearance: Xenophagy of intracellular pathogens

Signaling Integration

mTORC1 coordination: Integrates growth factor and nutrient signals
AMPK response: Energy stress activates BECN2-mediated autophagy
Receptor tyrosine kinase signaling: Modulates EGFR and insulin receptor trafficking

Molecular Mechanisms

PI3K Complex Formation

BECN2 assembles the class III PI3K complex:

| Component | Function |
|-----------|----------|
| VPS34 (PIK3C3) | Lipid kinase, generates PI3P |
| VPS15 (PIK3R4) | Regulatory subunit, kinase activity |
| BECN2 | Scaffold, substrate recruitment |
| ATG14L | Targeting to autophagosomes |

Autophagy Regulation

Initiation: BECN2-PI3P complex nucleates phagophore

Expansion: LC3-II recruited via LIR domain

Closure: Autophagosome membrane fusion

Fusion: Lysosomal fusion via SNARE proteins

Protein Interactions

| Partner | Interaction Type | Functional Outcome |
|---------|-----------------|-------------------|
| BCL2/BCL-XL | BH3 domain binding | Inhibits autophagy |
| VPS34 | CCD domain | PI3K complex |
| LC3/GABARAP | LIR motif | Autophagosome targeting |
| p62/SQSTM1 | Co-operation | Selective autophagy |
| OPTN | Co-operation | Ubiquitin selective autophagy |

Role in Neurodegeneration

Alzheimer's Disease

Amyloid clearance: BECN2-mediated autophagy clears [Aβ](/proteins/amyloid-beta) aggregates
[Tau](/proteins/tau) pathology: Impaired autophagy contributes to [tau](/proteins/tau) accumulation
Synaptic dysfunction: Autophagic-lysosomal pathway disruption in AD
Neuronal vulnerability: BECN2 reduction in AD brain

Parkinson's Disease

[α-Synuclein](/proteins/alpha-synuclein) clearance: BECN2-dependent mitophagy clears damaged mitochondria
Mitochondrial quality control: PINK1/Parkin-BECN2 axis
Lewy body formation: Impaired autophagic clearance
Dopaminergic neuron survival: BECN2 protection in PD models

Huntington's Disease

Mutant [huntingtin](/proteins/huntingtin-protein) clearance: [Autophagy](/entities/autophagy) induction via BECN2
Aggregate removal: Reduction of mHTT aggregates
Neuronal protection: BECN2 overexpression improves phenotype

ALS

Protein aggregate clearance: [TDP-43](/proteins/tdp-43), SOD1 aggregate removal
Axonal transport: Autophagosome-lysosome trafficking
Motor neuron survival: BECN2 protective in mouse models

Therapeutic Implications

Autophagy Modulators

| Compound | Mechanism | Stage |
|----------|-----------|-------|
| Rapamycin | [mTOR](/entities/mtor) inhibition | Preclinical |
| Metformin | AMPK activation | Clinical trials |
| Carbamazepine | Beclin-1 cleavage | Preclinical |
| Vitamin D | BECN2 upregulation | Observational |

Gene Therapy Approaches

AAV-BECN2: Viral delivery of BECN2
BECN2 activators: Small molecule allosteric modulators
miRNA targeting: Anti-miR therapy to upregulate BECN2

Combination Strategies

Autophagy + proteasome: Dual-target approaches
BECN2 + [TFEB](/entities/tfeb): Coordinated upregulation
Anti-aggregation + clearance: Comprehensive therapy

Biomarkers

BECN2 expression: Peripheral blood mononuclear cells
Autophagy flux: LC3-II/LC3-I ratio
p62 levels: Autophagy substrate clearance

Animal Models

Knockout Studies

Becn2⁻/⁻ mice: Embryonic lethal (different from Becn1)
Conditional knockout: Neurodegeneration phenotype
Tissue-specific deletion: Neuronal loss, aggregate formation

Transgenic Models

BECN2 overexpression: Neuroprotection in AD/PD models
Humanized BECN2: Studying human-specific functions
Mutant BECN2: Disease-associated variants

Key Findings

BECN2 haploinsufficiency enhances neurodegeneration

Autophagy induction protects against protein aggregates

BECN2-PI3K complex is druggable target

Research Directions

Emerging Questions

How does BECN2 specificity arise for different cargo?
What determines neuronal vulnerability to BECN2 loss?
Can BECN2 activation be achieved safely in humans?

Novel Approaches

Single-cell proteomics: BECN2 heterogeneity in neurons
CRISPR screens: Genetic modifiers of BECN2 function
Structural biology: BECN2-PI3K complex cryo-EM

Background

The study of Becn2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

[UniProt: BECN2](https://www.uniprot.org/uniprot/Q9U6C4)
[GeneCards: BECN2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=BECN2)
[OMIM: BECN2](https://www.omim.org/entry/611539)
[NCBI Gene: BECN2](https://www.ncbi.nlm.nih.gov/gene/151246)

References

[Mizushima N, Yoshimori T, Ohsumi Y, The role of Atg proteins in autophagosome formation (2011)](https://pubmed.ncbi.nlm.nih.gov/21801009/)

[Klionsky DJ, et al, Guidelines for the use and interpretation of assays for monitoring autophagy (2016)](https://pubmed.ncbi.nlm.nih.gov/26799652/)

[Galluzzi L, et al, Molecular definitions of autophagy and related processes (2017)](https://pubmed.ncbi.nlm.nih.gov/28923597/)

[Bento CF, et al, Mammalian autophagy: how does it work? Annu Rev Biochem (2016)](https://pubmed.ncbi.nlm.nih.gov/26865832/)

[Karan S, et al, Autophagy in neurodegenerative diseases: from pathogenesis to therapy (2021)](https://pubmed.ncbi.nlm.nih.gov/33737189/)

[Nah J, et al, Beclin-2 functions in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32632350/)

[Wang RC, et al, Akt-mediated regulation of autophagy and tumorigenesis through Beclin 1 phosphorylation (2012)](https://pubmed.ncbi.nlm.nih.gov/23112296/)

[He C, et al, Exercise-induced BCL2-mediated autophagy is required for muscle glucose homeostasis (2012)](https://pubmed.ncbi.nlm.nih.gov/22258505/)

📖 View canonical wiki page →

BECN2 Protein

BECN2 Protein (Beclin-2)

Introduction

Overview

Protein Structure

BECN2 Protein (Beclin-2)

Introduction

Overview

Protein Structure

Expression Pattern

Normal Function

Autophagy Initiation

Selective Autophagy Receptor

Signaling Integration

Molecular Mechanisms

PI3K Complex Formation

Autophagy Regulation

Protein Interactions

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Huntington's Disease

ALS

Therapeutic Implications

Autophagy Modulators

Gene Therapy Approaches

Combination Strategies

Biomarkers

Animal Models

Knockout Studies

Transgenic Models

Key Findings

Research Directions

Emerging Questions

Novel Approaches

Background

See Also

External Links

References